Browsing by Author "Panchia, Ravindre"
Now showing items 1-18 of 18
-
Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077
Tolley, Elizabeth E. et al. | Date Issued: 2020 -
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
Cohen, Myron S. et al. | Date Issued: 2016 -
Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052
Palumbo, Philip J. et al. | Date Issued: 2017 -
Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial
Fogel, Jessica M. et al. | Date Issued: 2016 -
Cabotegravir is not associated with weight gain in HIV-uninfected individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2019 -
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus–uninfected Individuals in HPTN 077
Landovitz, Raphael J. et al. | Date Issued: 2020 -
A comparison of hepatitis B virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical trial: HPTN 052
Greer, Amy E. et al. | Date Issued: 2017 -
Comparison of hepatitis B virus infection in HIV-infected and HIV-uninfected participants enrolled in a multinational clinical Trial: HPTN 052
Greer, Amy E. et al. | Date Issued: 2017 -
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Grinsztein, Beatriz et al. | Date Issued: 2014 -
HIV drug resistance in adults receiving early versus delayed antiretroviral therapy: HPTN 052
Palumbo, Philip J. et al. | Date Issued: 2018 -
HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052
Palumbo, Philip J. et al. | Date Issued: 2017 -
Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study
Seneviratne, Herana Kamal et al. | Date Issued: 2021 -
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
Landovitz, Raphael J et al. | Date Issued: 2018 -
Sexually transmitted infections among HIV serodiscordant partners: A secondary analysis of HIV Prevention Trial Network 052
Chagomerana, Maganizo B et al. | Date Issued: 2021 -
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
Landovitz, Raphael J. et al. | Date Issued: 2020 -
Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial
Eshleman, Susan H. et al. | Date Issued: 2017 -
Undisclosed Antiretroviral Drug Use in a Multinational Clinical Trial (HIV Prevention Trials Network 052)
Fogel, Jessica M. et al. | Date Issued: 2013 -
Virologic outcomes in early antiretroviral treatment: HPTN 052
Eshleman, Susan H. et al. | Date Issued: 2017